Zimmer Biomet appoints Kevin Thornal as Group President, Global Businesses and the Americas effective July 1, 2025

ZIMMER BIOMET HOLDINGS, INC.

Thornal appointed to new role effective July 1; reports to CEO Ivan Tornos, leads Americas and global business units.
Former Nevro CEO and Hologic Group President; previously held leadership at Stryker.
Mark Bezjak remains President Americas but ceases as executive officer upon Thornal's start.
Compensation: $850k base, 100% target bonus, ~$5.3M in equity (RSUs + PRSUs); eligible for severance plans.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin Thornal

Group President, Global Businesses and the Americas

ZBH · ZIMMER BIOMET HOLDINGS, INC.

Effective: 2025-07-01
Filed: May 27, 2025 23:59 UTC

Kevin Thornal has been appointed to the newly-created position of Group President, Global Businesses and the Americas of the Company, effective July 1, 2025.

Departed

Mark Bezjak

President, Americas

ZBH · ZIMMER BIOMET HOLDINGS, INC.

Effective: 2025-07-01
Filed: May 27, 2025 23:59 UTC

Mark Bezjak, President, Americas, will continue to hold such office but will cease to be an executive officer of the Company at the time Mr. Thornal joins the Company.

Source: SEC EDGAR

accession 0001193125-25-126231

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.